Abstract 270: Patients With Acute Ischemic Stroke and Associated Diagnosis of Obstructive Sleep Apnea Have Lower In-hospital Mortality

2019 ◽  
Vol 12 (Suppl_1) ◽  
Author(s):  
Wojciech Rzechorzek ◽  
Kirtipal Bhatia ◽  
Bharat Narasimhan ◽  
Michel Skaf ◽  
Eyal Herzog
2021 ◽  
pp. neurintsurg-2021-018161
Author(s):  
Justin M Lapow ◽  
Alis J Dicpinigaitis ◽  
Rajkumar S Pammal ◽  
Griffin A Coghill ◽  
Osher Rechester ◽  
...  

BackgroundObstructive sleep apnea (OSA) portends increased morbidity and mortality following acute ischemic stroke (AIS). Evaluation of OSA in the setting of AIS treated with endovascular mechanical thrombectomy (MT) has not yet been evaluated in the literature.MethodsThe National Inpatient Sample from 2010 to 2018 was utilized to identify adult AIS patients treated with MT. Those with and without OSA were compared for clinical characteristics, complications, and discharge disposition. Multivariable logistic regression analysis and propensity score adjustment (PA) were employed to evaluate independent associations between OSA and clinical outcome.ResultsAmong 101 093 AIS patients treated with MT, 6412 (6%) had OSA. Those without OSA were older (68.5 vs 65.6 years old, p<0.001), female (50.5% vs 33.5%, p<0.001), and non-caucasian (29.7% vs 23.7%, p<0.001). The OSA group had significantly higher rates of obesity (41.4% vs 10.5%, p<0.001), atrial fibrillation (47.1% vs 42.2%, p=0.001), hypertension (87.4% vs 78.5%, p<0.001), and diabetes mellitus (41.2% vs 26.9%, p<0.001). OSA patients treated with MT demonstrated lower rates of intracranial hemorrhage (19.1% vs 21.8%, p=0.017), treatment of hydrocephalus (0.3% vs 1.1%, p=0.009), and in-hospital mortality (9.7% vs 13.5%, p<0.001). OSA was independently associated with lower rate of in-hospital mortality (aOR 0.76, 95% CI 0.69 to 0.83; p<0.001), intracranial hemorrhage (aOR 0.88, 95% CI 0.83 to 0.95; p<0.001), and hydrocephalus (aOR 0.51, 95% CI 0.37 to 0.71; p<0.001). Results were confirmed by PA.ConclusionsOur findings suggest that MT is a viable and safe treatment option for AIS patients with OSA.


2019 ◽  
Vol 16 (2) ◽  
pp. 88-94
Author(s):  
Su-Hyun Han ◽  
Kwang-Yeol Park ◽  
Yong Sung Kim ◽  
Jeong-Min Kim ◽  
Seo-Young Lee

2018 ◽  
Vol 36 (6) ◽  
pp. 1351-1359 ◽  
Author(s):  
Paola Mattaliano ◽  
Carolina Lombardi ◽  
Davide Sangalli ◽  
Andrea Faini ◽  
Barbara Corrà ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document